Voelker Dayne, Pitlick Mitchell, Gonzalez-Estrada Alexei, Park Miguel
Mayo Clinic School of Graduate Medical Education, Mayo Clinic, Rochester, Minn.
Division of Pulmonary, Allergy and Sleep Medicine, Department of Medicine, Mayo Clinic, Jacksonville, Fla.
J Allergy Clin Immunol Pract. 2020 Jun;8(6):1980-1986.e7. doi: 10.1016/j.jaip.2020.01.039. Epub 2020 Jan 30.
The positive rate and pattern of penicillin skin test (PST) has been reported to be decreasing and changing. Previous studies differ about which penicillin component is the dominant component in positive PST result.
To characterize past and current PST patterns to determine whether different determinants in PST have changed over time.
A retrospective review of electronic medical records (January 2001-December 2017) was performed for patients who underwent PST. Data were divided into 4 cohorts to see whether trends occurred over time. The cohorts were divided as follows: cohort 1 (2001-2005), cohort 2 (2006-2010), cohort 3 (2011-2015), and cohort 4 (2016-2017).
A total of 30,883 patients underwent PST with the following breakdowns per cohort: cohort 1, 6,536; cohort 2, 10,372; cohort 3, 10,640; and cohort 4, 3,335. Of these, 329 patients (1.0%) had a positive PST result with a wheal of 3 × 3 mm or greater, with 110 in cohort 1, 130 in cohort 2, 67 in cohort 3, and 22 in cohort 4, whereas 170 patients (0.5%) had a positive PST result with a wheal of 5 × 5 mm or greater, with 54 in cohort 1, 72 in cohort 2, 34 in cohort 3, and 10 in cohort 4. When the positive PST rates of cohort 2 (1.25%), cohort 3 (0.6%), and cohort 4 (0.6%) were compared with those of cohort 1 (1.7%), there was a significant decrease in positive PST rates (P = .0278; P < .0001; P < .0001, respectively). When cohort 1 positive rate to benzylpenicillin polylysine among the positive PST (wheal of 3 × 3 mm or greater) was compared with those of the other cohorts (cohorts 2-4), the percent positive of benzylpenicillin polylysine in PST was 27% compared with 21% (P = .38), 34% (P = .5), and 18% (P = .6), respectively. When the positive PST result was defined as a wheal of 5 × 5 mm or greater, the positive rate for benzylpenicillin polylysine in PST increased over time (cohort 2: 22%, P = .8; cohort 3: 32%, P = .3; cohort 4: 40%, P = .264) compared with cohort 1 (19%).
Positive PST rate is decreasing. We demonstrate that despite benzylpenicillin polylysine solely positive rates remaining relatively stable, the minor penicillin determinants and amoxicillin play an important role in PST and their adoption into standard protocol for routine PST should be considered.
据报道,青霉素皮肤试验(PST)的阳性率和模式一直在下降和变化。以往的研究对于在PST阳性结果中哪种青霉素成分是主要成分存在分歧。
描述过去和当前的PST模式,以确定PST中的不同决定因素是否随时间发生了变化。
对接受PST的患者的电子病历(2001年1月至2017年12月)进行回顾性研究。数据被分为4个队列,以观察是否随时间出现趋势变化。队列划分如下:队列1(2001 - 2005年)、队列2(2006 - 2010年)、队列3(2011 - 2015年)和队列4(2016 - 2017年)。
共有30883例患者接受了PST,各队列情况如下:队列1有6536例,队列2有10372例,队列3有10640例,队列4有3335例。其中,329例患者(1.0%)PST结果为阳性,风团大小为3×3mm或更大,队列1中有110例,队列2中有130例,队列3中有67例,队列4中有22例;而170例患者(0.5%)PST结果为阳性,风团大小为5×5mm或更大,队列1中有54例,队列2中有72例,队列3中有34例,队列4中有10例。将队列2(阳性率1.25%)、队列3(阳性率0.6%)和队列4(阳性率0.6%)的PST阳性率与队列1(阳性率1.7%)进行比较,PST阳性率有显著下降(P分别为0.0278、P < 0.0001、P < 0.0001)。将队列1中PST阳性(风团大小为3×3mm或更大)患者中对苄星青霉素赖氨酸的阳性率与其他队列(队列2 - 4)进行比较,PST中苄星青霉素赖氨酸的阳性百分比分别为27%、21%(P = 0.38)、34%(P = 0.5)和18%(P = 0.6)。当将PST阳性结果定义为风团大小为5×5mm或更大时,与队列1(19%)相比,PST中苄星青霉素赖氨酸的阳性率随时间增加(队列2:22%,P = 0.8;队列3:32%,P = 0.3;队列4:40%,P = 0.264)。
PST阳性率正在下降。我们证明,尽管苄星青霉素赖氨酸单独的阳性率保持相对稳定,但次要青霉素决定因素和阿莫西林在PST中起重要作用,应考虑将它们纳入常规PST的标准方案中。